Integrated Biologics: Enabling high throughput drug discovery at Amgen
White Paper Jan 04, 2019
Large molecule discovery and development is a complex series of interwoven cycles that span many teams within a research and development organization. By making a commitment to informatics, Amgen pioneered the shift to large molecules and was on the forefront of addressing the complexity of large molecule discovery.
Download this case study to learn:
- The challenges faced by the high throughput biologics team at Amgen.
- How a highly integrated, biologics LIMS accelerated generation of breakthrough large molecule therapeutics.
- How implementation translated into significant return on investment.